Advancing ADC and Drug Product Solutions: CARBOGEN AMCIS Expertise Tuesday, 10 October 2023
Watch Episode 2 of our Customer Journey series on CARBOGEN AMCIS Drug Products, ADC & Bioconjugation services!
Watch Episode 2 of our Customer Journey series on CARBOGEN AMCIS Drug Products, ADC & Bioconjugation services!
Brochure
Learn more about our Bioconjugation & Antibody Drug Conjugates services at CARBOGEN AMCIS
CARBOGEN AMCIS & Heidelberg Pharma Formula for Successful Collaboration
During the BOS Basel 2022 Heidelberg Pharma and CARBOGEN AMCIS presented their collaboration and fully synthetic route for α-Amanitin.
Discovering a new ADC
After intense research investigations Heidelberg Pharma found a unique access to a fully synthetic route for α-Amanitin. With CARBOGEN AMCIS, Heidelberg Pharma developed a scalable and economical route providing α-Amanitin now available for the development of new therapeutic ADC’s.